Evidence map›Paper›PMID 39998123›Full record

ArticleJournal of virology2025

Single-cell delineation of strain-specific HIV-1 Vif activities using dual reporter sensor cells and live cell imaging.

Jorge F Guerrero, Laraine L Zimdars, James W Bruce, Jordan T Becker, Edward L Evans, Soroosh Torabi, Rob Striker, Scott M Berry, Nathan M Sherer

Abstract read
In one paragraph

Article in Journal of virology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Manipulation of the cell cycle by HIV-1.Biochemical Society transactions · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jorge F GuerreroMcArdle Laboratory for Cancer Research (Department of Oncology), University of Wisconsin-Madison, Madison, Wisconsin, USA.ORCID 0000-0002-4510-5151
Laraine L ZimdarsMcArdle Laboratory for Cancer Research (Department of Oncology), University of Wisconsin-Madison, Madison, Wisconsin, USA.
James W BruceMcArdle Laboratory for Cancer Research (Department of Oncology), University of Wisconsin-Madison, Madison, Wisconsin, USA.
Jordan T BeckerMcArdle Laboratory for Cancer Research (Department of Oncology), University of Wisconsin-Madison, Madison, Wisconsin, USA.
Edward L EvansMcArdle Laboratory for Cancer Research (Department of Oncology), University of Wisconsin-Madison, Madison, Wisconsin, USA.
Soroosh TorabiDepartment of Mechanical Engineering, University of Kentucky, Lexington, Kentucky, USA.
Rob StrikerDepartment of Medicine, University of Wisconsin-Madison, Madison, Wisconsin, USA.ORCID 0000-0002-0454-895X
Scott M BerryDepartment of Mechanical Engineering, University of Kentucky, Lexington, Kentucky, USA.
Nathan M ShererMcArdle Laboratory for Cancer Research (Department of Oncology), University of Wisconsin-Madison, Madison, Wisconsin, USA.ORCID 0000-0001-9974-236X

Funding

UW COMPREHENSIVE CANCER CENTER SUPPORTP30CA014520 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI AMY TRENTHAM-DIETZ · 1985 to 2026
$142.6M
Center for Structural Biology of HIV RNAU54AI170660 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ALICE TELESNITSKY · 2022 to 2026
$32.1M
Training in Cancer Biology Training GrantT32CA009135 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI SUGDEN, WILLIAM M. · 1985 to 2024
$10.4M
Training Program In Molecular AND Cellular PharmacologyT32GM008688 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI AUDHYA, ANJON · 1998 to 2020
$6.0M
The Cell Biology of HIV-1 Genome TraffickingR01AI110221 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI Nathan M Sherer · 2014 to 2026
$4.4M
Graduate Training in Molecular and Cellular PharmacologyT32GM141013 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI Anjon Audhya, Aaron Matthew LeBeau · 2021 to 2026
$3.2M
The Cell Biology of HIV-1 Genome TraffickingR56AI110221 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI SHERER, NATHAN M · 2024 to 2024
$457k
The Dual Reporter Sensor Cell (DRSC) Assay: An Enhanced Tool for Measuring the Viral ReservoirR21AI155008 · NIAID · UNIVERSITY OF KENTUCKY · PI BERRY, SCOTT M, SHERER, NATHAN M · 2020 to 2021
$360k
NCI NIH HHS P30 CA014520NCI NIH HHS T32 CA009135NIAID NIH HHS R01 AI110221NIAID NIH HHS R21 AI155008NIAID NIH HHS R56 AI110221NIAID NIH HHS U54 AI170660NIGMS NIH HHS T32 GM008688NIGMS NIH HHS T32 GM141013
6 · The paper itself

Abstract

Human immunodeficiency virus type 1 (HIV-1) genome diversification is a key determinant of viral evolution and the pathogenesis of HIV/AIDS. Antiretroviral therapy is non-curative, and in the context of monitoring the latent reservoir, precision tools are needed to detect and enumerate HIV-1 genomes as well as to assess their heterogeneity, replication potential, and predict responses to therapy. Current sequencing-based methodologies are often unable to confirm intact genomes and most cell-based reporters provide limited information pertaining to viral fitness. In this study, we describe dual reporter sensor cells (DRSCs), an imaging-based reporter system designed to detect HIV-1 infection and measure several independent attributes of the virus in a single-cell high-content assay. We show that the DRSC assay can be used to measure infection, viral gene activation kinetics, and quantify viral circumvention of host antiviral responses. Using the DRSCs, we confirmed markedly different functional heterogeneity for IMPORTANCE: Human immunodeficiency virus type 1 (HIV-1) is highly heterogeneous and constantly mutating. These changes drive immune evasion and can cause treatment efforts to fail. Here, we describe the "dual reporter sensor cell" (DRSC) assay; a novel imaging-based approach that allows for the detection of HIV-1 infection coupled with a multivariate definition of several independent phenotypic aspects of viral genome activity in a single integrated assay. We validate the DRSC system by studying lab-adapted and patient isolate-derived versions of the viral Vif accessory protein, confirming marked differences in the capacity of diverse

Indexed as

HIV-1HIV InfectionsSingle-Cell Analysisvif Gene Products, Human Immunodeficiency VirusGenes, ReporterGenome, ViralHEK293 CellsHumansVirus Replicationvif Gene Products, Human Immunodeficiency Virusvif protein, Human immunodeficiency virus 1APOBEC3Gcell cyclegenome diversificationHIVimage analysislive cell imagingreporter cellVif

Identifiers

PMID39998123
PMCPMC11915839

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.